id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-N-1482-4372,FDA,FDA-2019-N-1482,Cannabidiol and Other Cannabinoids: Sex and Gender Differences in Use and Responses; Public Meeting,Notice,Public Meetings,2020-09-23T04:00:00Z,2020,9,2020-09-23T04:00:00Z,,2020-09-23T12:46:14Z,2020-21023,0,0,0900006484872da4
FDA-2019-N-1482-4341,FDA,FDA-2019-N-1482,"Scientific Data and Information About Products Containing Cannabis or
Cannabis-Derived Compounds; Reopening of the Comment Period",Notice,Extension of Comment Period,2020-03-11T04:00:00Z,2020,3,2020-03-11T04:00:00Z,2019-04-04T03:59:59Z,2020-03-11T12:36:34Z,2020-04919,0,0,0900006484434bdc